Latest filing published 29 May 2024 for LifeStance Health Group, Inc., €8.8M.
Filing timeline
BuySaleInsider track record
Jeffrey Crisan: trading record in brief
This profile gathers the share dealings of Jeffrey Crisan across 3 companies, led by LifeStance Health Group, Inc., Nanosphere Inc and Princeton Review Inc. The record holds 8 filings, for trades running from 6 November 2007 to 24 May 2024.
On the market, this insider has only sold: 3 sales, €24.0M in total. Outside the open market, there are 1 share grant. In 2024 alone, the filings show no purchases and 1 sale.
Most recently, on 29 May 2024, the filings show an open-market sale worth €8.8M in LifeStance Health Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey Crisan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,624,638 shares@ US$5.89100.0% of flowCommon StockSEC:0000950170-24-066040:0
- 487,391 shares@ US$17.01100.0% of flowCommon StockSEC:0000899243-21-026588:0
- 584,870 shares@ US$17.0154.1% of flowCommon StockSEC:0000899243-21-024158:1
- 20,613,453 sharesCommon StockSEC:0000899243-21-024158:0
- 35,640 sharesSeries E Non-Convertible Preferred StockSEC:0001181431-10-022691:0
- 35,640 sharesSeries E Non-Convertible Preferred StockSEC:0001181431-10-022691:1
- 244,692 sharesCommon StockSEC:0001181431-07-067658:0
- 15,713 sharesCommon StockSEC:0001181431-07-067658:1
8 of 6 declarations
